Skip to main content
Journal cover image

Occult malignancy in patients with suspected paraneoplastic neurologic syndromes: value of positron emission tomography in diagnosis.

Publication ,  Journal Article
Patel, RR; Subramaniam, RM; Mandrekar, JN; Hammack, JE; Lowe, VJ; Jett, JR
Published in: Mayo Clin Proc
August 2008

OBJECTIVE: To determine the value of positron emission tomography (PET) in diagnosing occult malignancies in patients with paraneoplastic neurologic syndromes (PNSs) at Mayo Clinic's site in Rochester, MN. PATIENTS AND METHODS: We retrospectively reviewed the medical charts of all 107 patients who underwent PET from January 1, 2000, to July 31, 2006, for the indication of suspected PNS. Three patients did not meet inclusion criteria. PET results were considered positive if increased fludeoxyglucose F 18 uptake indicated malignancy (24 patients). Results from computed tomography were interpreted as positive if any suspect lesion was consistent with malignancy (26 patients). RESULTS: One hundred four patients with PNS were identified from the PET central database; 73 patients had at least 1 positive result for paraneoplastic antibody, and 31 had antibody-negative PNS. Malignancy was confirmed pathologically in 10 patients, of whom 8 had positive PET results. There were 2 cases of confirmed malignancy (fallopian tube adenocarcinoma and spindle cell uterine carcinoma) for which PET results were negative. Two patients with positive PET results declined biopsy. Computed tomography was able to identify 3 of the 10 malignancies detected. Five cases of malignancy were detected only by PET. All patients with confirmed malignancy had positive results for at least 1 paraneoplastic antibody. One patient with positive results for PNS antibody and negative PET results was diagnosed as having small cell carcinoma on a follow-up PET scan after 27 months. PET had sensitivity, specificity, positive predictive value, and negative predictive value of 80%, 67%, 53%, and 88%, respectively. CONCLUSION: PET scan was shown to be more sensitive than computed tomography for detecting occult malignancy (confirmed by positive test results for autoantibody) among patients with suspected PNS. The greatest clinical utility of PET could be in its high negative predictive value.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Mayo Clin Proc

DOI

EISSN

1942-5546

Publication Date

August 2008

Volume

83

Issue

8

Start / End Page

917 / 922

Location

England

Related Subject Headings

  • Sensitivity and Specificity
  • Retrospective Studies
  • Radiopharmaceuticals
  • Predictive Value of Tests
  • Positron-Emission Tomography
  • Paraneoplastic Syndromes, Nervous System
  • Middle Aged
  • Male
  • Humans
  • Fluorodeoxyglucose F18
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Patel, R. R., Subramaniam, R. M., Mandrekar, J. N., Hammack, J. E., Lowe, V. J., & Jett, J. R. (2008). Occult malignancy in patients with suspected paraneoplastic neurologic syndromes: value of positron emission tomography in diagnosis. Mayo Clin Proc, 83(8), 917–922. https://doi.org/10.4065/83.8.917
Patel, Rajesh R., Rathan M. Subramaniam, Jaywant N. Mandrekar, Julie E. Hammack, Val J. Lowe, and James R. Jett. “Occult malignancy in patients with suspected paraneoplastic neurologic syndromes: value of positron emission tomography in diagnosis.Mayo Clin Proc 83, no. 8 (August 2008): 917–22. https://doi.org/10.4065/83.8.917.
Patel RR, Subramaniam RM, Mandrekar JN, Hammack JE, Lowe VJ, Jett JR. Occult malignancy in patients with suspected paraneoplastic neurologic syndromes: value of positron emission tomography in diagnosis. Mayo Clin Proc. 2008 Aug;83(8):917–22.
Patel, Rajesh R., et al. “Occult malignancy in patients with suspected paraneoplastic neurologic syndromes: value of positron emission tomography in diagnosis.Mayo Clin Proc, vol. 83, no. 8, Aug. 2008, pp. 917–22. Pubmed, doi:10.4065/83.8.917.
Patel RR, Subramaniam RM, Mandrekar JN, Hammack JE, Lowe VJ, Jett JR. Occult malignancy in patients with suspected paraneoplastic neurologic syndromes: value of positron emission tomography in diagnosis. Mayo Clin Proc. 2008 Aug;83(8):917–922.
Journal cover image

Published In

Mayo Clin Proc

DOI

EISSN

1942-5546

Publication Date

August 2008

Volume

83

Issue

8

Start / End Page

917 / 922

Location

England

Related Subject Headings

  • Sensitivity and Specificity
  • Retrospective Studies
  • Radiopharmaceuticals
  • Predictive Value of Tests
  • Positron-Emission Tomography
  • Paraneoplastic Syndromes, Nervous System
  • Middle Aged
  • Male
  • Humans
  • Fluorodeoxyglucose F18